NCT04413955View on ClinicalTrials.gov

Registry of Seraph®-100 Microbind® Affinity Blood Filter for COVID-19 Under EUA

CompletedOBSERVATIONAL
Enrollment

15

Participants

Timeline

Start Date

June 1, 2020

Primary Completion Date

December 31, 2021

Study Completion Date

January 31, 2022

Conditions
COVID-19SARS-CoV 2
Interventions
DEVICE

Seraph®-100 Microbind® Affinity Blood Filter

Use of an extracorporeal broad-spectrum sorbent hemoperfusion filter to removed SARS-CoV-2 virus and circulating cytokines from the blood

Trial Locations (1)

45229

Cincinnati Children's Hospital Medical Center, Cincinnati

Sponsors
All Listed Sponsors
collaborator

ExThera Medical Corporation

INDUSTRY

lead

Children's Hospital Medical Center, Cincinnati

OTHER

NCT04413955 - Registry of Seraph®-100 Microbind® Affinity Blood Filter for COVID-19 Under EUA | Biotech Hunter | Biotech Hunter